Realize one thing about editors: When a story tailor-made for a great headline crosses our paths, it will make its way to print. Case in point, Wrigley's (Chicago) recent announcement of a patent for a gum infused with a version of Pfizer- (New York) owned Viagra. Unfortunately, decorum prevents many headline suggestions from making their way to print.
Readers may recall that Pfizer is the pharmaceutical giant that sold Adams (and its Dentyne, Bubblicious, Clorets, Certs and Halls brands of gums and mints) to Wrigley competitor Cadbury Schweppes (London). Pfizer also has announced that it is studying lozenges and tablets as delivery vehicles other than the little blue pill.